Medicine Grade Lapatinib Ditosylate Powder CAS 388082-78-8 925.46 Molecular Weight

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Antineoplastic Drugs API - 70
Minimum Order Quantity: 1KG
Price: Negotiation
Packaging Details: Aluminum foil bag, fiber can, kraft paper bag
Delivery Time: Within 7 days
Supply Ability: Can be customized according to customer requirements
Detail Information
Name: Lapatinib Ditosylate CAS: 388082-78-8
Appearance: Powder Molecular Formula: C41H40ClFN4O11S3
Molecular Weight: 925.46 Purity: 99%
High Light:

chemical raw materials


pharmaceutical raw materials

Product Description

Lapatinib ditosylate CAS 388082-78-8 Pharmaceutical Grade Chemicals



Lapatinib produced by glaxosmithkline. Epidermal growth factor receptor tyrosine kinase inhibitor, an oral administration of small molecules. Mainly used for joint card of capecitabine in the treatment of erbB-2 overexpression, who previously received including anthracyclines and paclitaxel and trastuzumab (Herceptin) in the treatment of advanced or metastatic breast cancer. When taking the need to pay attention to its adverse reactions.




Content: >99%
Appearance A white,Crystalline Powder
Formula C29H26ClFN4O4S
Molecular Weight 581.06
Moisture <1mg/mL
Loss on Drying ≤0.2%
Residue on ignition ≤0.1%
Boiling Point 750.7°C at 760 mmHg
Flash(ing) point 407.8°C
Stability at -20°C 2 years
Heavy Metals ≤10PPM
Acidity or Alkalinity Conform
Chloride: Conform
Readily Carbonizable Substances Conform
Ordinary Impurities Conform



It is used in combination with capecitabine to treat over expression of advanced or metastatic breast cancer that has previously been treated with anthracycline, paclitaxel, and trastuzumab (Herceptin).


Our strengths:
We can customize according to customer's requirement.
If you have any question pls mail us or call us.


Contact Details

Phone Number : +86 18989305995

WhatsApp : +18989305995